45 results
Page 3 of 3
8-K
EX-99.1
ntn3n 1dl8
6 Nov 19
Aeglea BioTherapeutics Reports Third Quarter 2019 Financial Results and Corporate Highlights
8:30am
8-K
EX-99.4
jv009ro40yslf0h5uln
3 Sep 19
Aeglea BioTherapeutics Announces Positive 20-Dose Data for Pegzilarginase in Patients with Arginase 1 Deficiency at the 2019 SSIEM Symposium
6:03am
8-K
EX-99.3
6jx6u5
8 Apr 19
Regulation FD Disclosure
6:05am